Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis

NCT00676832 is registered in ClinicalTrials.gov with Prometheus Laboratories as lead sponsor.

NCT NCT00676832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00676832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Lead sponsor
Prometheus Laboratories
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2008
Completion date
October 31, 2009
Enrollment
190 (actual)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative